Literature DB >> 3337557

The Kaplan and Meier and the Nelson estimate for the probability of ulcer recurrence 10 and 15 years after parietal cell vagotomy.

S Meisner1, L N Jørgensen, H E Jensen.   

Abstract

The use of a nonparametric estimate from incomplete observations is demonstrated on ulcer recurrence 10-15 years after parietal cell vagotomy in 339 patients with duodenal ulcer. The median period of observation was 108 months (range: 1-197 months). Proven recurrent ulcer developed in 62 patients. The life-table method as described by Kaplan and Meier and Nelson's modification are demonstrated. The calculated risk of recurrence after 10 years was 23% (+/- 3.8%) and after 15 years was 27% (+/- 4.3%). The rate of recurrence seemed to decline toward the end of the trial time.

Entities:  

Mesh:

Year:  1988        PMID: 3337557      PMCID: PMC1493255          DOI: 10.1097/00000658-198801000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Selective vagotomy of the parietal cell mass preserving innervation of the undrained antrum. A preliminary report of results in patients with duodenal ulcer.

Authors:  E Amdrup; H E Jensen
Journal:  Gastroenterology       Date:  1970-10       Impact factor: 22.682

2.  Selective vagotomy with innervated antrum without drainage procedure for duodenal ulcer.

Authors:  D Johnston; A Wilkinson
Journal:  Br J Surg       Date:  1969-08       Impact factor: 6.939

3.  Ulcer recurrence two to twelve years after parietal cell vagotomy for duodenal ulcer.

Authors:  H E Jensen; J Kjaergaard; S Meisner
Journal:  Surgery       Date:  1983-11       Impact factor: 3.982

4.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

5.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  5 in total
  4 in total

Review 1.  Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.

Authors:  L B Barradell; D McTavish
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

Review 2.  Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: a systematic review.

Authors:  Richard H Turnage; George Sarosi; Byron Cryer; Stuart Spechler; Walter Peterson; Mark Feldman
Journal:  J Gastrointest Surg       Date:  2003 Jul-Aug       Impact factor: 3.452

Review 3.  Complications associated with ulcer recurrence following gastric surgery for ulcer disease.

Authors:  J G Penston; E J Boyd; K G Wormsley
Journal:  Gastroenterol Jpn       Date:  1992-02

4.  Indications for parietal cell vagotomy without drainage in gastrointestinal surgery.

Authors:  P H Jordan
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.